Artelo Bioscience (NASDAQ: ARTL) announced Tuesday morning its research collaboration with Trinity College Dublin, investigating ART27.13 to treat Cancer Cachexia.
Artelo shares surged 72% premarket and are now trading around the $1.29 level, a 24% increase from Monday’s close.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
There has been a lot of talk on social media about the company, with rumours on a potential short squeeze affecting its share price. They were recently upgraded from hold to a buy at Maxim.
The company will be researching with Trinity College Dublin to investigate preclinical human cancer cachexia models, a wasting syndrome that affects up to 80% of cancer patients. They will work with Artelo’s peripherally restricted cannabinoid receptor agonist, ART27.13, in preclinical models of human cancer cachexia.
The company is now advancing the ART27.13 program with the Cancer Appetite Recovery Study, a Phase 1b/2a study in patients with cancer-related anorexia.
“I am excited to partner with Artelo to expand the research around ART27.13 for the treatment of cachexia” stated Dr Richard K. Porter, Head of the Trinity team.
“I believe this is a very important and exciting area of research as there is the potential of a significant impact on patients’ quality of life during a very vulnerable time in their lives”
Gregory Gorgas, Artelo’s President and CEO, commented, “We are delighted to enter into a collaboration with Trinity College Dublin, as this research will be key to advancing our understanding of ART27.13’s breadth of activity and helping us guide future clinical development for this program.”
